n-glycylalanine has been researched along with tanespimycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barlow, EA; Burgess, RR; Duellman, SJ; Hagemeier, SR; Kenney, SC; Khanna, R; Ma, S; Sun, X; Tellam, J | 1 |
Kenney, SC; Sun, X | 1 |
2 other study(ies) available for n-glycylalanine and tanespimycin
Article | Year |
---|---|
Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism.
Topics: Animals; Apoptosis; Benzoquinones; Cell Line, Tumor; Dipeptides; DNA Primers; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Viral; Herpesvirus 4, Human; HSP90 Heat-Shock Proteins; Humans; Immunoblotting; Immunoprecipitation; Lactams, Macrocyclic; Lymphoproliferative Disorders; Mice; Mice, SCID; Reverse Transcriptase Polymerase Chain Reaction; Virus Replication | 2010 |
Hsp90 inhibitors: a potential treatment for latent EBV infection?
Topics: Antiviral Agents; Benzoquinones; Dipeptides; Epstein-Barr Virus Infections; Herpesvirus 4, Human; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Viral Proteins | 2010 |